Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 474

1.

Central auditory processing in adults with chronic stroke without hearing loss: A magnetoencephalography study.

Fujioka T, Freigang C, Honjo K, Chen JJ, Chen JL, Black SE, Stuss DT, Dawson DR, Ross B.

Clin Neurophysiol. 2020 Feb 6;131(5):1102-1118. doi: 10.1016/j.clinph.2020.01.014. [Epub ahead of print]

PMID:
32200092
2.

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease.

Bawa KK, Krance SH, Herrmann N, Cogo-Moreira H, Ouk M, Yu D, Wu CY, Black SE, Lanctôt KL, Swardfager W; Alzheimer’s Disease Neuroimaging Initiative.

J Neuroinflammation. 2020 Mar 14;17(1):84. doi: 10.1186/s12974-020-01750-3.

3.

Outcomes of Endovascular Thrombectomy for Basilar Artery Occlusion.

Pasarikovski CR, Khosravani H, da Costa L, Heyn C, Priola SM, Ku JC, Black SE, Gladstone D, Yang VX.

Can J Neurol Sci. 2020 Mar 6:1-18. doi: 10.1017/cjn.2020.51. [Epub ahead of print] No abstract available.

PMID:
32138792
4.

Reduced Cognitive Assessment Scores Among Individuals With Magnetic Resonance Imaging-Detected Vascular Brain Injury.

Anand SS, Friedrich MG, Desai D, Schulze KM, Awadalla P, Busseuil D, Dummer TJB, Jacquemont S, Dick A, Kelton D, Kirpalani A, Lear SA, Leipsic J, Noseworthy MD, Parker L, Parraga G, Poirier P, Robson P, Tardif JC, Teo K, Vena J, Yusuf S, Moody AR, Black SE, Smith EE; Canadian Alliance for Healthy Hearts and Minds Cohort.

Stroke. 2020 Apr;51(4):1158-1165. doi: 10.1161/STROKEAHA.119.028179. Epub 2020 Mar 4.

PMID:
32126938
5.

Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.

Kapoor A, Bartha R, Black SE, Borrie M, Freedman M, Gao F, Herrmann N, Mandzia J, Ozzoude M, Ramirez J, Scott CJM, Symons S, Fischer CE, Frank A, Seitz D, Wolf MU, Verhoeff NPLG, Naglie G, Reichman W, Masellis M, Mitchell SB, Tang-Wai DF, Tartaglia C, Kumar S, Pollock BG, Rajji TK, Finger E, Pasternak SH; ONDRI Investigators, Swartz RH.

J Alzheimers Dis. 2020 Feb 24. doi: 10.3233/JAD-191097. [Epub ahead of print]

PMID:
32116253
6.

Perivascular spaces in the brain: anatomy, physiology and pathology.

Wardlaw JM, Benveniste H, Nedergaard M, Zlokovic BV, Mestre H, Lee H, Doubal FN, Brown R, Ramirez J, MacIntosh BJ, Tannenbaum A, Ballerini L, Rungta RL, Boido D, Sweeney M, Montagne A, Charpak S, Joutel A, Smith KJ, Black SE; colleagues from the Fondation Leducq Transatlantic Network of Excellence on the Role of the Perivascular Space in Cerebral Small Vessel Disease.

Nat Rev Neurol. 2020 Mar;16(3):137-153. doi: 10.1038/s41582-020-0312-z. Epub 2020 Feb 24. Review.

PMID:
32094487
7.

Embolic Stroke of Undetermined Source and Sleep Disorders.

Dharmakulaseelan L, Chan-Smyth N, Black SE, Swartz RH, Murray BJ, Boulos MI.

Stroke. 2020 Apr;51(4):1294-1296. doi: 10.1161/STROKEAHA.119.028796. Epub 2020 Feb 11.

PMID:
32078473
8.

Impaired perception of simultaneous stimuli in a patient with posterior cortical atrophy: an attentional account.

Fernandez-Duque D, Black SE.

Neurocase. 2020 Feb 18:1-10. doi: 10.1080/13554794.2020.1729385. [Epub ahead of print]

PMID:
32070200
9.

Optical coherence tomography imaging after endovascular thrombectomy: a novel method for evaluating vascular injury in a swine model.

Pasarikovski CR, Keith J, da Costa L, Ramjist J, Dobashi Y, Black SE, Yang VXD.

J Neurosurg. 2020 Feb 14:1-8. doi: 10.3171/2019.12.JNS192881. [Epub ahead of print]

PMID:
32059182
10.

Slowed Temporal and Parietal Cerebrovascular Response in patients with Alzheimer's Disease.

Holmes KR, Tang-Wai D, Sam K, McKetton L, Poublanc J, Crawley AP, Sobczyk O, Cohn M, Duffin J, Tartaglia MC, Black SE, Fisher JA, Wasserman B, Mikulis DJ.

Can J Neurol Sci. 2020 Feb 13:1-28. doi: 10.1017/cjn.2020.30. [Epub ahead of print] No abstract available.

PMID:
32051047
11.

Neuropathology of a remarkable case of memory impairment informs human memory.

Gao AF, Keith JL, Gao FQ, Black SE, Moscovitch M, Rosenbaum RS.

Neuropsychologia. 2020 Mar 16;140:107342. doi: 10.1016/j.neuropsychologia.2020.107342. Epub 2020 Jan 20.

PMID:
31972232
12.

Neuropathology of Speech Network Distinguishes Bulbar From Nonbulbar Amyotrophic Lateral Sclerosis.

Shellikeri S, Keith J, Black SE, Zinman L, Yunusova Y.

J Neuropathol Exp Neurol. 2020 Mar 1;79(3):284-295. doi: 10.1093/jnen/nlz130.

PMID:
31951003
13.

A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.

Badhwar A, McFall GP, Sapkota S, Black SE, Chertkow H, Duchesne S, Masellis M, Li L, Dixon RA, Bellec P.

Brain. 2019 Dec 31. pii: awz384. doi: 10.1093/brain/awz384. [Epub ahead of print]

PMID:
31891371
14.

Comparison of quality control methods for automated diffusion tensor imaging analysis pipelines.

Haddad SMH, Scott CJM, Ozzoude M, Holmes MF, Arnott SR, Nanayakkara ND, Ramirez J, Black SE, Dowlatshahi D, Strother SC, Swartz RH, Symons S, Montero-Odasso M; ONDRI Investigators, Bartha R.

PLoS One. 2019 Dec 20;14(12):e0226715. doi: 10.1371/journal.pone.0226715. eCollection 2019.

15.

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

Moore KM, Nicholas J, Grossman M, McMillan CT, Irwin DJ, Massimo L, Van Deerlin VM, Warren JD, Fox NC, Rossor MN, Mead S, Bocchetta M, Boeve BF, Knopman DS, Graff-Radford NR, Forsberg LK, Rademakers R, Wszolek ZK, van Swieten JC, Jiskoot LC, Meeter LH, Dopper EG, Papma JM, Snowden JS, Saxon J, Jones M, Pickering-Brown S, Le Ber I, Camuzat A, Brice A, Caroppo P, Ghidoni R, Pievani M, Benussi L, Binetti G, Dickerson BC, Lucente D, Krivensky S, Graff C, Öijerstedt L, Fallström M, Thonberg H, Ghoshal N, Morris JC, Borroni B, Benussi A, Padovani A, Galimberti D, Scarpini E, Fumagalli GG, Mackenzie IR, Hsiung GR, Sengdy P, Boxer AL, Rosen H, Taylor JB, Synofzik M, Wilke C, Sulzer P, Hodges JR, Halliday G, Kwok J, Sanchez-Valle R, Lladó A, Borrego-Ecija S, Santana I, Almeida MR, Tábuas-Pereira M, Moreno F, Barandiaran M, Indakoetxea B, Levin J, Danek A, Rowe JB, Cope TE, Otto M, Anderl-Straub S, de Mendonça A, Maruta C, Masellis M, Black SE, Couratier P, Lautrette G, Huey ED, Sorbi S, Nacmias B, Laforce R Jr, Tremblay ML, Vandenberghe R, Damme PV, Rogalski EJ, Weintraub S, Gerhard A, Onyike CU, Ducharme S, Papageorgiou SG, Ng ASL, Brodtmann A, Finger E, Guerreiro R, Bras J, Rohrer JD; FTD Prevention Initiative.

Lancet Neurol. 2020 Feb;19(2):145-156. doi: 10.1016/S1474-4422(19)30394-1. Epub 2019 Dec 3. Erratum in: Lancet Neurol. 2020 Feb;19(2):e2.

16.

Cognition in Stroke Rehabilitation and Recovery Research: Consensus-Based Core Recommendations From the Second Stroke Recovery and Rehabilitation Roundtable.

McDonald MW, Black SE, Copland DA, Corbett D, Dijkhuizen RM, Farr TD, Jeffers MS, Kalaria RN, Karayanidis F, Leff AP, Nithianantharajah J, Pendlebury S, Quinn TJ, Clarkson AN, O'Sullivan MJ.

Neurorehabil Neural Repair. 2019 Nov;33(11):943-950. doi: 10.1177/1545968319886444. Epub 2019 Oct 29.

PMID:
31660787
17.

Hippocampal segmentation for brains with extensive atrophy using three-dimensional convolutional neural networks.

Goubran M, Ntiri EE, Akhavein H, Holmes M, Nestor S, Ramirez J, Adamo S, Ozzoude M, Scott C, Gao F, Martel A, Swardfager W, Masellis M, Swartz R, MacIntosh B, Black SE.

Hum Brain Mapp. 2020 Feb 1;41(2):291-308. doi: 10.1002/hbm.24811. Epub 2019 Oct 14.

PMID:
31609046
18.

APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia.

Mirza SS, Saeed U, Knight J, Ramirez J, Stuss DT, Keith J, Nestor SM, Yu D, Swardfager W, Rogaeva E, St George Hyslop P, Black SE, Masellis M; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2019 Nov 5;93(19):e1807-e1819. doi: 10.1212/WNL.0000000000008377. Epub 2019 Oct 1.

19.

Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease.

Anand SS, Tu JV, Desai D, Awadalla P, Robson P, Jacquemont S, Dummer T, Le N, Parker L, Poirier P, Teo K, Lear SA, Yusuf S, Tardif JC, Marcotte F, Busseuil D, Després JP, Black SE, Kirpalani A, Parraga G, Noseworthy MD, Dick A, Leipsic J, Kelton D, Vena J, Thomas M, Schulze KM, Larose E, Moody AR, Smith EE, Friedrich MG; Canadian Alliance for Healthy Hearts and Minds Cohort .

Eur Heart J Cardiovasc Imaging. 2019 Sep 30. pii: jez226. doi: 10.1093/ehjci/jez226. [Epub ahead of print]

PMID:
31565735
20.

First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound.

Abrahao A, Meng Y, Llinas M, Huang Y, Hamani C, Mainprize T, Aubert I, Heyn C, Black SE, Hynynen K, Lipsman N, Zinman L.

Nat Commun. 2019 Sep 26;10(1):4373. doi: 10.1038/s41467-019-12426-9.

21.

Lactate topography of the human brain using hyperpolarized 13C-MRI.

Lee CY, Soliman H, Geraghty BJ, Chen AP, Connelly KA, Endre R, Perks WJ, Heyn C, Black SE, Cunningham CH.

Neuroimage. 2020 Jan 1;204:116202. doi: 10.1016/j.neuroimage.2019.116202. Epub 2019 Sep 23.

22.

Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation.

Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL.

J Geriatr Psychiatry Neurol. 2019 Sep 23:891988719874118. doi: 10.1177/0891988719874118. [Epub ahead of print]

PMID:
31547752
23.

Special topic section: linkages among cerebrovascular, cardiovascular, and cognitive disorders: Preventing dementia by preventing stroke: The Berlin Manifesto.

Hachinski V, Einhäupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, Sweeney MD, Zlokovic B, Iturria-Medina Y, Iadecola C, Nishimura N, Schaffer CB, Whitehead SN, Black SE, Østergaard L, Wardlaw J, Greenberg S, Friberg L, Norrving B, Rowe B, Joanette Y, Hacke W, Kuller L, Dichgans M, Endres M, Khachaturian ZS.

Int J Stroke. 2019 Sep 22:1747493019871915. doi: 10.1177/1747493019871915. [Epub ahead of print]

PMID:
31543058
24.

Glymphatics Visualization after Focused Ultrasound-Induced Blood-Brain Barrier Opening in Humans.

Meng Y, Abrahao A, Heyn CC, Bethune AJ, Huang Y, Pople CB, Aubert I, Hamani C, Zinman L, Hynynen K, Black SE, Lipsman N.

Ann Neurol. 2019 Dec;86(6):975-980. doi: 10.1002/ana.25604. Epub 2019 Oct 17.

PMID:
31525269
25.

Increased Diameters of the Internal Cerebral Veins and the Basal Veins of Rosenthal Are Associated with White Matter Hyperintensity Volume.

Houck AL, Gutierrez J, Gao F, Igwe KC, Colon JM, Black SE, Brickman AM.

AJNR Am J Neuroradiol. 2019 Oct;40(10):1712-1718. doi: 10.3174/ajnr.A6213. Epub 2019 Sep 12.

26.

Cognition in stroke rehabilitation and recovery research: Consensus-based core recommendations from the second Stroke Recovery and Rehabilitation Roundtable.

McDonald MW, Black SE, Copland DA, Corbett D, Dijkhuizen RM, Farr TD, Jeffers MS, Kalaria RN, Karayanidis F, Leff AP, Nithianantharajah J, Pendlebury S, Quinn TJ, Clarkson AN, O'Sullivan MJ.

Int J Stroke. 2019 Oct;14(8):774-782. doi: 10.1177/1747493019873600. Epub 2019 Sep 12.

PMID:
31514685
27.

Actigraphic measures of sleep on the wards after ICU discharge.

Wilcox ME, Rubenfeld GD, Walczak KD, Black SE, McAndrews MP, Lim AS.

J Crit Care. 2019 Dec;54:163-169. doi: 10.1016/j.jcrc.2019.08.006. Epub 2019 Aug 16.

PMID:
31472397
28.

Optical coherence tomography imaging after endovascular thrombectomy for basilar artery occlusion: report of 3 cases.

Pasarikovski CR, Ramjist J, da Costa L, Black SE, Yang V.

J Neurosurg. 2019 Aug 23:1-6. doi: 10.3171/2019.5.JNS191252. [Epub ahead of print]

PMID:
31443067
29.

The Canadian Dementia Imaging Protocol: Harmonization validity for morphometry measurements.

Potvin O, Chouinard I, Dieumegarde L, Bartha R, Bellec P, Collins DL, Descoteaux M, Hoge R, Ramirez J, Scott CJM, Smith EE, Strother SC, Black SE, Duchesne S; CIMA-Q group; CCNA group.

Neuroimage Clin. 2019;24:101943. doi: 10.1016/j.nicl.2019.101943. Epub 2019 Jul 18.

30.

Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.

Krance SH, Cogo-Moreira H, Rabin JS, Black SE, Swardfager W; Alzheimer's Disease Neuroimaging Initiative.

J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.

31.

The Use of Random Forests to Classify Amyloid Brain PET.

Zukotynski K, Gaudet V, Kuo PH, Adamo S, Goubran M, Scott C, Bocti C, Borrie M, Chertkow H, Frayne R, Hsiung R, Laforce R Jr, Noseworthy MD, Prato FS, Sahlas DJ, Smith EE, Sossi V, Thiel A, Soucy JP, Tardif JC, Black SE.

Clin Nucl Med. 2019 Oct;44(10):784-788. doi: 10.1097/RLU.0000000000002747.

PMID:
31348088
32.

Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial.

Ruthirakuhan MT, Herrmann N, Gallagher D, Andreazza AC, Kiss A, Verhoeff NPLG, Black SE, Lanctôt KL.

Contemp Clin Trials Commun. 2019 May 23;15:100385. doi: 10.1016/j.conctc.2019.100385. eCollection 2019 Sep.

33.

Preventing dementia by preventing stroke: The Berlin Manifesto.

Hachinski V, Einhäupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, Sweeney MD, Zlokovic B, Iturria-Medina Y, Iadecola C, Nishimura N, Schaffer CB, Whitehead SN, Black SE, Østergaard L, Wardlaw J, Greenberg S, Friberg L, Norrving B, Rowe B, Joanette Y, Hacke W, Kuller L, Dichgans M, Endres M, Khachaturian ZS.

Alzheimers Dement. 2019 Jul;15(7):961-984. doi: 10.1016/j.jalz.2019.06.001. Review.

34.

24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone.

Ruthirakuhan M, Herrmann N, Andreazza AC, Verhoeff NPLG, Gallagher D, Black SE, Kiss A, Lanctôt KL.

J Alzheimers Dis. 2019;71(1):21-31. doi: 10.3233/JAD-190202.

35.

The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study.

Chertkow H, Borrie M, Whitehead V, Black SE, Feldman HH, Gauthier S, Hogan DB, Masellis M, McGilton K, Rockwood K, Tierney MC, Andrew M, Hsiung GR, Camicioli R, Smith EE, Fogarty J, Lindsay J, Best S, Evans A, Das S, Mohaddes Z, Pilon R, Poirier J, Phillips NA, MacNamara E, Dixon RA, Duchesne S, MacKenzie I, Rylett RJ.

Can J Neurol Sci. 2019 Sep;46(5):499-511. doi: 10.1017/cjn.2019.27. Epub 2019 Jul 16.

PMID:
31309917
36.

Resting state functional connectivity changes after MR-guided focused ultrasound mediated blood-brain barrier opening in patients with Alzheimer's disease.

Meng Y, MacIntosh BJ, Shirzadi Z, Kiss A, Bethune A, Heyn C, Mithani K, Hamani C, Black SE, Hynynen K, Lipsman N.

Neuroimage. 2019 Oct 15;200:275-280. doi: 10.1016/j.neuroimage.2019.06.060. Epub 2019 Jun 26.

PMID:
31254646
37.

Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative.

Dilliott AA, Evans EC, Farhan SMK, Ghani M, Sato C, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, Bulman DE, Rogaeva E, Black SE, Finger E, Frank A, Freedman M, Hassan A, Lang A, Shoesmith CL, Swartz RH, Tang-Wai D, Tartaglia MC, Turnbull J, Zinman L; ONDRI Investigators, Hegele RA.

Can J Neurol Sci. 2019 Sep;46(5):491-498. doi: 10.1017/cjn.2019.228. Epub 2019 Aug 15.

PMID:
31217043
38.

Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.

Herrmann N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, Kiss A, Black SE, Lanctôt KL.

Am J Geriatr Psychiatry. 2019 Nov;27(11):1161-1173. doi: 10.1016/j.jagp.2019.05.002. Epub 2019 May 8.

39.

Optical Coherence Tomography as an Adjunct During Carotid Artery Stenting for Carotid Atherosclerotic Disease.

Pasarikovski CR, Ramjist J, da Costa L, Black SE, Cardinell J, Yang VX.

Clin Neuroradiol. 2019 May 31. doi: 10.1007/s00062-019-00799-9. [Epub ahead of print]

PMID:
31152190
40.

Speech network regional involvement in bulbar ALS: a multimodal structural MRI study.

Shellikeri S, Myers M, Black SE, Abrahao A, Zinman L, Yunusova Y.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):385-395. doi: 10.1080/21678421.2019.1612920. Epub 2019 May 14.

PMID:
31088163
41.

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.

Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, Fossati S, Gottesman RF, Gustafson DR, Hachinski V, Hayden KM, Helman AM, Hughes TM, Isaacs JD, Jefferson AL, Johnson SC, Kapasi A, Kern S, Kwon JC, Kukolja J, Lee A, Lockhart SN, Murray A, Osborn KE, Power MC, Price BR, Rhodius-Meester HFM, Rondeau JA, Rosen AC, Rosene DL, Schneider JA, Scholtzova H, Shaaban CE, Silva NCBS, Snyder HM, Swardfager W, Troen AM, van Veluw SJ, Vemuri P, Wallin A, Wellington C, Wilcock DM, Xie SX, Hainsworth AH.

Alzheimers Dement (N Y). 2019 Apr 9;5:107-117. doi: 10.1016/j.trci.2019.02.001. eCollection 2019. Review.

42.

Frontal Anatomical Correlates of Cognitive and Speech Motor Deficits in Amyotrophic Lateral Sclerosis.

Yunusova Y, Ansari J, Ramirez J, Shellikeri S, Stanisz GJ, Black SE, Gillingham SM, Kiss A, Stuss DT, Zinman L.

Behav Neurol. 2019 Mar 13;2019:9518309. doi: 10.1155/2019/9518309. eCollection 2019.

43.

Cognitive heterogeneity among community-dwelling older adults with cerebral small vessel disease.

Dey AK, Stamenova V, Bacopulos A, Jeyakumar N, Turner GR, Black SE, Levine B.

Neurobiol Aging. 2019 May;77:183-193. doi: 10.1016/j.neurobiolaging.2018.12.011. Epub 2019 Jan 5.

PMID:
30875655
44.

Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration.

Smith EE, Biessels GJ, De Guio F, de Leeuw FE, Duchesne S, Düring M, Frayne R, Ikram MA, Jouvent E, MacIntosh BJ, Thrippleton MJ, Vernooij MW, Adams H, Backes WH, Ballerini L, Black SE, Chen C, Corriveau R, DeCarli C, Greenberg SM, Gurol ME, Ingrisch M, Job D, Lam BYK, Launer LJ, Linn J, McCreary CR, Mok VCT, Pantoni L, Pike GB, Ramirez J, Reijmer YD, Romero JR, Ropele S, Rost NS, Sachdev PS, Scott CJM, Seshadri S, Sharma M, Sourbron S, Steketee RME, Swartz RH, van Oostenbrugge R, van Osch M, van Rooden S, Viswanathan A, Werring D, Dichgans M, Wardlaw JM.

Alzheimers Dement (Amst). 2019 Feb 26;11:191-204. doi: 10.1016/j.dadm.2019.01.002. eCollection 2019 Dec. Review.

45.

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.

Mutsaerts HJMM, Mirza SS, Petr J, Thomas DL, Cash DM, Bocchetta M, de Vita E, Metcalfe AWS, Shirzadi Z, Robertson AD, Tartaglia MC, Mitchell SB, Black SE, Freedman M, Tang-Wai D, Keren R, Rogaeva E, van Swieten J, Laforce R, Tagliavini F, Borroni B, Galimberti D, Rowe JB, Graff C, Frisoni GB, Finger E, Sorbi S, de Mendonça A, Rohrer JD, MacIntosh BJ, Masellis M; GENetic Frontotemporal dementia Initiative (GENFI).

Brain. 2019 Apr 1;142(4):1108-1120. doi: 10.1093/brain/awz039. Erratum in: Brain. 2019 Jun 1;142(6):e28.

46.

Machine Learning in Nuclear Medicine: Part 1-Introduction.

Uribe CF, Mathotaarachchi S, Gaudet V, Smith KC, Rosa-Neto P, Bénard F, Black SE, Zukotynski K.

J Nucl Med. 2019 Apr;60(4):451-458. doi: 10.2967/jnumed.118.223495. Epub 2019 Feb 7. Review.

47.

BOLD-based cerebrovascular reactivity vascular transfer function isolates amplitude and timing responses to better characterize cerebral small vessel disease.

Atwi S, Shao H, Crane DE, da Costa L, Aviv RI, Mikulis DJ, Black SE, MacIntosh BJ.

NMR Biomed. 2019 Mar;32(3):e4064. doi: 10.1002/nbm.4064. Epub 2019 Jan 29.

PMID:
30693582
48.

Vascular dysfunction-The disregarded partner of Alzheimer's disease.

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Salman RA, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, González HM, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O'Brien JT, Skoog I, Pantoni L, Gustafson DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV.

Alzheimers Dement. 2019 Jan;15(1):158-167. doi: 10.1016/j.jalz.2018.07.222.

49.

The Canadian Dementia Imaging Protocol: Harmonizing National Cohorts.

Duchesne S, Chouinard I, Potvin O, Fonov VS, Khademi A, Bartha R, Bellec P, Collins DL, Descoteaux M, Hoge R, McCreary CR, Ramirez J, Scott CJM, Smith EE, Strother SC, Black SE; CIMA-Q group and the CCNA group.

J Magn Reson Imaging. 2019 Feb;49(2):456-465. doi: 10.1002/jmri.26197. Epub 2018 Sep 17.

PMID:
30635988
50.

Alcohol use and dementia: a systematic scoping review.

Rehm J, Hasan OSM, Black SE, Shield KD, Schwarzinger M.

Alzheimers Res Ther. 2019 Jan 5;11(1):1. doi: 10.1186/s13195-018-0453-0.

Supplemental Content

Loading ...
Support Center